Administrative/Regulatory,
Health Care & Hospital Law
Aug. 24, 2023
Fifth Circuit medication abortion ruling could affect more than abortion access
The case threatens the FDA’s regulatory authority and could lead to established, safe medications being challenged simply because they are politically contentious.
Cathren Cohen
Staff Attorney
UCLA Law Center
Reproductive, Health, Law, and Policy
Email: cohenc@law.ucla.edu
Abortion medication has become crucial to access in a post-Dobbs landscape, where more than half of U.S. states have or are expected to ban or severely restrict abortion rights. Even before Roe was overturned, medication abortions made up more than half of abortions in the U.S. Since $95
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In